openPR Logo
Press release

Gonorrhea Diagnostic Market Analysis Till 2027 - New Study By Coherent Market Insights

07-21-2021 09:37 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Gonorrhea Diagnostic Market

Gonorrhea Diagnostic Market

Gonorrhea is a sexually transmitted disease caused by a bacterium Neisseria Gonorrhoeae. It is one of the most common sexually transmitted diseases and affects millions of people each year. According to the study, ‘Global epidemiology of Neisseria gonorrhoeae in infertile populations: systematic review, meta-analysis and metaregression’, published in BMJ Journals in May 2020, the pooled mean prevalence of current gonorrhoea infection worldwide was at 2.2%, with the highest prevalence in Africa at 5.0%. Thus, high prevalence of gonorrhea in emerging economies is expected to propel growth of the gonorrhea diagnostic market.

Request PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/126

Diagnostic tools available in the gonorrhea diagnostic market include urine test, swab test and nucleic acid amplification testing (NAAT). The gonorrhea diagnostic market is witnessing R&D of new approaches for diagnosis. In May 2021, researchers from Johns Hopkins University reported development of PROMPT (portable, rapid, on-cartridge, magnetofluidic purification and testing platform), an inexpensive portable device and a complimenting smartphone app that can diagnose gonorrhea infection in under 15 minutes. The study was published in Science Translational Medicine.

Emergence of Covid-19 has led to significant rise in sexually transmitted diseases, which is also expected to aid in growth of the gonorrhea diagnostic market. In November 2020, a study conducted in two main STI centers in Milan, Italy, revealed that diagnosis of STIs, including gonorrhea, secondary syphilis and mycoplasma genitalium (MG) has increased despite the lockdown restrictions. The study results were presented at the 29th European Academy of Dermatology and Venereology virtual conference.

Players in the gonorrhea diagnostic market are focused on expanding their distribution channel. In February 2021, Binx Health, a provider of point-of-care diagnostic solutions, partnered with McKesson, a healthcare company, for the sale and distribution of the Binx io molecular diagnostic testing platform in the US. The point-of-care platform enables the diagnosis and subsequent treatment of chlamydia and gonorrhea to take place in a single visit. Later, in April 2021, the Food and Drug Administration granted a CLIA waiver for the binx health io CT/NG assay, thereby allowing the use of the binx health io CT/NG assay at point-of-care settings.

Purchase Report at: https://www.coherentmarketinsights.com/promo/buynow/126

The gonorrhea diagnostic market in North America is expected to witness significant growth with surge in cases of gonorrhea infections. According to a Michigan Department of Health and Human Services press release, in Michigan reported a 22% increase in reported gonorrhea infections for 2020 compared to 18,264 gonorrhea infections in 2019.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gonorrhea Diagnostic Market Analysis Till 2027 - New Study By Coherent Market Insights here

News-ID: 2333477 • Views:

More Releases from Coherent Market Insights

Global Antihistamine Drugs Market Expected to Expand at a Steady 2024-2031 | Bayer AG, Almirall  S.A, GlaxoSmithKline, Johnson and Johnson.
Global Antihistamine Drugs Market Expected to Expand at a Steady 2024-2031 | Bay …
Coherent Market Insights introduces new research on the Global Antihistamine Drugs Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also
Incretin Mimetics Market Future Business Opportunities 2024-2031 | GSK, Novo Nordisk, Lily, Haosoh, Sanofi, AstraZeneca, Pfizer Inc.
Incretin Mimetics Market Future Business Opportunities 2024-2031 | GSK, Novo Nor …
Coherent Market Insights introduces new research on the Incretin Mimetics Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also focuses
Skin Rash Treatment Market Huge Growth in Future Scope 2024-2031 | AbbVie, Amgen, Bristol Myers Squibb, Galderma, Johnson & Johnson.
Skin Rash Treatment Market Huge Growth in Future Scope 2024-2031 | AbbVie, Amgen …
Coherent Market Insights introduces new research on the Skin Rash Treatment Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also
Global Vitamin API Market Growth in Future Scope 2024-2031 | DSM, BASF, BOC Sciences, CSPC Pharmaceutical Group Limited.
Global Vitamin API Market Growth in Future Scope 2024-2031 | DSM, BASF, BOC Scie …
Coherent Market Insights introduces new research on the Global Vitamin API Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also

All 5 Releases


More Releases for Gonorrhea

Gonorrhea - Drug Pipeline Landscape, 2022
Gonorrhea is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae. Gonorrhea most often affects the urethra, r*ctum or throat. In females, gonorrhea can also infect the cervix. Symptoms of Gonorrhea infection in men include painful urination, pain or swelling in one t*sticle and in women include increased vaginal discharge, painful urination, vaginal bleeding between periods and abdominal or pelvic pain. Diagnosis of Gonorrhea can be done after
Gonorrhea - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Gonorrhea - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gonorrhea - Pipeline Review, H2 2017, provides an overview of the Gonorrhea (Infectious Disease) pipeline landscape. Gonorrhea is an infection caused by a sexually transmitted bacterium that can infect both males and females. Gonorrhea most often affects
Gonorrhea Testing Market Snapshot by 2017 – 2025
Gonorrhea is one of the very common sexually transmitted disease (STD), which is basically an inflammation on mucous membrane surface caused by microorganism Neisseria gonorrhoeae. The infection can affect both men and women. In women, the infection grows in moist & warmth area of reproductive track including uterus, cervix, and fallopian tube. The infection also grows in mouth, throat, urethra and anus, in both men and women. Most of the
Gonorrhea Diagnostics Market Information - Forecast To 2023
Gonorrhea is a sexually transmitted disease caused by the bacterium Neisseria gonorrhoeae and can affect both genders. It is a common infection, especially among young people aged between 15 years to 24 years. According to the U.S. Centers for Disease Control and Prevention (CDC), gonorrhea is the second most commonly reported disease in the United States affecting approximately 800,000 people each year. In the United Kingdom, about 28,000 cases of
Global Gonorrhea Diagnostics Market Research Report 2017
Global Gonorrhea Diagnostics Industry 2017 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2017-2020. A new research report on the global Gonorrhea Diagnostics market offers a 360-degree overview of it. The report discusses the market in significant details and elucidates all aspects of the global Gonorrhea Diagnostics market likely to impact its growth trajectory in the upcoming years. Major market stimulants and
Global Gonorrhea Diagnostics Market Research Report 2017
This report studies Gonorrhea Diagnostics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Abbott Laboratories Beckman Coulter Roche Diagnostics Siemens Agilent Technologies Alere Becton Dickinson and Company F.Hoffmann-La Roche AG Tosoh Corporation PerkinElmer,Inc Bio-Rad Request Sample Report: http://www.reportbazzar.com/request-sample/?pid=888233&ptitle=Global+Gonorrhea+Diagnostics+Market+Research+Report+2017&req=Sample Cepheid Diamedix Kyowa Medex Lonza Mackay Life Sciences Nihon Kohden Ortho Clinical Diagnostics Polymedco Qiagen SDIX Sequenom Sienco Sysmex Takara Bio Market Segment by Regions, this report splits Global into several key Regions, with production,